The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy

Author:

Ali Nidhal,Sebastian Cherry,Foley Rosemary R.,Murray Iain,Canizales Ana L.,Jenkins Paul J.,Drake William M.,Nicholas Plowman P.,Michael Besser G.,Chew Shern L.,Grossman Ashley B.,Monson John P.,Britton Keith E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference32 articles.

1. A national cancer data-base on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995;Hundahl;Cancer,1998

2. Long term treatment results of 283 patients with lung and bone metastases from differentiated thyroid carcinoma;Schlumberger;J Clin Endocrinol Metab,1986

3. Clinical Review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer;Mazzaferri;J Clin Endocrinol Metab,2001

4. Limitation in the treatment of cancer of the thyroid with radioactive iodine;Rawson;J Clin Endocrinol Metab,1951

5. Potential adverse effect of high-dose 131I survey scanning in the management of differentiated thyroid carcinomas (Abstract);Park;Eur J Nucl Med,1990

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3